ea0081ep304 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022
Tassone Francesco
, Ferreri Cinzia
, Rossi Arianna
, Baffoni Claudia
, Borretta Giorgio
, Feola Mauro
Background: Sodium-glucose cotransporter-2 (SGLT2) inhibitors demonstrated beneficial effects on cardiovascular and renal events in patients with type 2 diabetes mellitus. The mechanisms underlying these effects are not fully elucidated. Aim of this study was to investigate whether empagliflozin is able to affect arterial stiffness/pulse wave velocity in type 2 diabetic patients.Methods: Pulse wave velocity and other parameters of arterial stiffness were...